Skip to content

Clinical trials

Phase 3 Osteoporosis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Osteoporosis Phase: Phase 3 Clear all

179 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20005
200110
200212
200315
200419
200514
200618
200711
20089
200911
20107
20118
20126
20131
20143
20161
20173
20185
20194
20211
20221
20244
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed150
Terminated12
Unknown status11
Withdrawn5
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen17
Novartis Pharmaceuticals13
Eli Lilly and Company8
Merck Sharp & Dohme LLC6
Organon and Co6
Novartis5
Radius Health, Inc.5
Alliance for Clinical Trials in Oncology4
Shire4
ETOP IBCSG Partners Foundation3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Osteoporosis179
Bone Diseases, Metabolic40
Osteoporosis, Postmenopausal24
Breast Neoplasms13
Fractures, Bone11
Prostatic Neoplasms9
Bone Diseases5
Osteoporotic Fractures5
Cardiovascular Diseases4
Diabetes Mellitus3

Trials

Showing 26 to 50 of 179. Each trial links to its page on Pharma Observatory.

79 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.